The Bulletin
The Times


.

Alebund's AP301 NDA Accepted for Review by China's NMPA

  • Written by PR Newswire

SHANGHAI, Aug. 7, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"; HKEX: 09637), a renal-focused biopharmaceutical company, today announced that the New Drug Application (NDA) for AP301 capsules, a novel oral iron-based phosphate binder, for the treatment of hyperphosphatemia in patients with chronic...

The Bulletin Magazine

The Essential Bathroom Renovation Supplies Checklist Before You Start

Pull Up Stands: A Convenient Display Option for Events and Promotions

How Mining Hose Selection Can Improve Material Transfer Systems

Electric Sliding Door: What to Consider Before Choosing One

What Is Included in a Professional Roof Repair Service on the Gold Coast?

The Unglamorous Baby Buys That Save Australian Parents the Most Time

Cryptocurrency Trading in 2026_ Why Regulated Education Is the New Standard

How Mining Hose Routing Can Influence Wear and Transfer Efficiency

Cryotherapy in Melbourne: What Skin Lesions Can Be Treated with Targeted Cold Therapy?

10 Restaurants in Cranbourne You Need to Try Before 2027

ZOLL Defibrillators: Why They're a Leading Choice for Businesses, Warehouses, and Healthcare Settings

How Property Maintenance Issues Can Affect Commercial Tenancies

hacklink hack forum hacklink film izle hacklink non gamstop casinos ukcasinos not on gamstopnon gamstop casinocasinos not on gamstoponline gamblingbest casinos not on gamstopgambling sites not on gamstopgambling sites not on gamstopPadişahbetcasibomRoyal reelsThe PokiesBetpipoBetpipoVipparkPadişahbetGalabetimajbetcasibomcasibomcasinos not on gamstopnon uk casinosnot on gamstopcasinos not on gamstopcasinos non gamblock ukiptvcanlı maç izlezlibraryzlibraryz-libraryankara escortdeneme bonusuPadişahbetVipparkPadişahbetDeneme bonusuperabetPadişahbetmarsbahistaraftarium24jojobetmarsbahisSahabetjojobetsuperbetinmatbetjojobet